Fusion event
HBV-OR52A5 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACC| |AGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGGGCATGGACA
End
5152963/5131733 (Hg38)
Nearest miRNA
hsa-mir-210/Upstream/1275592; hsa-let-7a-2/Downstream/2103033;
Upstream sequence
ATTATATTTAGGTTTTTACTTAGAACCAACCCTAAATCTCTATAGGAGTCACTAACGATCAAGTTACTTTTTTGAAGAAAAACACTTTCACAATATGGTC
Downstream sequence
ACGAATTTGCTTGGTCTTCACTCCATAGACAATAGGGTTGAGAAAAGGTGGGACTAACAGGTAAAGATTTGACAAGAGGATATGAATATATGGTGGTATG
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.